Evaluation of Drug Display in Critical Care Setting
- Conditions
- Decision Making
- Interventions
- Device: medication monitor
- Registration Number
- NCT00715507
- Lead Sponsor
- University of Utah
- Brief Summary
To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.
- Detailed Description
This study has two objectives: First, before the medication monitor is shown to anesthesiologists in a clinical setting, the PKPD models must be validated to assess the clinical reliability of the model-based predictions for patients undergoing general anesthesia. Second, once the PKPD models have been successfully validated, presenting it to anesthesiologists during administration of anesthesia will assess the impact of the graphical medication monitor. Differences in performance and patient care will be determined by comparing anesthesiologists who are presented with the monitor to those who care for patients without the monitor.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents and have been trained on the graphic display
- Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents that have not been trained on the graphic display
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 2 medication monitor In the experimental condition, anesthesiologists will be shown the medication monitor to aid their expertise and decision-making.
- Primary Outcome Measures
Name Time Method assess differences between medication administration data and patient information with and without the use of the graphical medication monitor. preoperative, intraoperative and postoperative
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Utah
🇺🇸Salt Lake City, Utah, United States